International Urology and Nephrology

, Volume 49, Issue 7, pp 1217–1223 | Cite as

Lung function and impaired kidney function in relation to metabolic syndrome

  • Kayoung LeeEmail author
Nephrology - Original Paper



This study aimed to assess the relationships between abnormal lung function and indicators of chronic kidney disease in relation to metabolic syndrome (MetS) by using data from the 2011–2013 Korea National Health and Nutrition Examination Survey.


Using the data of 8551 Korean adults (3798 men, 4753 women, ≥40 years), lung function categories [obstructive lung disease (OLD), restrictive lung disease (RLD), and non-obstructive/non-restrictive lung disease (reference group)] were defined for each gender. Albuminuria and low estimated glomerular filtration rate (eGFR) were defined as urine albumin-to-creatinine ratio ≥30 mg/g and eGFR < 60 mL/min/1.73 m2. Gender-specific logistic regression analysis was performed after adjusting for age, educational level, smoking, alcohol use, physical activity, and medication use for chronic diseases.


Compared to the reference group, low eGFR was associated with higher odds for RLD in men and RLD or OLD in women when they did not have MetS. In those with MetS, low eGFR was associated with higher odds for OLD in men and RLD or OLD in women. Albuminuria was associated with higher odds for RLD in men who did not have MetS, while it was associated with higher odds for RLD or OLD in men and women who had MetS.


Abnormal lung function was associated with increased odds for chronic kidney disease indicators, when combined with MetS in both gender. Even in those without MetS, RLD in men was associated with increased odds for low eGFR or albuminuria, while RLD or OLD in women was associated with increased odds for low eGFR.


Lung function Metabolic syndrome Estimated glomerular filtration rate Albuminuria 


Compliance with ethical standards

Conflict of interest

The author declares that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128CrossRefPubMedGoogle Scholar
  2. 2.
    Jha V, Garcia-Garcia G, Iseki K et al (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260–272CrossRefPubMedGoogle Scholar
  3. 3.
    Incalzi RA, Corsonello A, Pedone C et al (2010) Chronic renal failure: a neglected comorbidity of COPD. Chest 137(4):831–837CrossRefPubMedGoogle Scholar
  4. 4.
    van Gestel YR, Chonchol M, Hoeks SE et al (2009) Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 24(9):2763–2767CrossRefPubMedGoogle Scholar
  5. 5.
    Bulcun E, Ekici M, Ekici A, Kisa U (2013) Microalbuminuria in chronic obstructive pulmonary disease. COPD 10(2):186–192CrossRefPubMedGoogle Scholar
  6. 6.
    Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD (2016) Obstructive and restrictive lung function measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007–2012. Am J Kidney Dis 68:414–421CrossRefPubMedGoogle Scholar
  7. 7.
    Romundstad S, Naustdal T, Romundstad PR, Sorger H, Langhammer A (2014) COPD and microalbuminuria: a 12-year follow-up study. Eur Respir J 43(4):1042–1050CrossRefPubMedGoogle Scholar
  8. 8.
    Rowley K, O’Dea K, Best JD (2003) Association of albuminuria and the metabolic syndrome. Curr Diab Rep 3(1):80–86CrossRefPubMedGoogle Scholar
  9. 9.
    Cebron Lipovec N, Beijers RJ, van den Borst B, Doehner W, Lainscak M, Schols AM (2016) The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD 13(3):399–406CrossRefPubMedGoogle Scholar
  10. 10.
    Ford ES, Cunningham TJ, Mercado CI (2014) Lung function and metabolic syndrome: findings of National Health and Nutrition Examination Survey 2007–2010. J Diabetes 6(6):603–613CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H (2008) A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 134(4):712–718CrossRefPubMedGoogle Scholar
  12. 12.
    Paek YJ, Jung KS, Hwang YI, Lee KS, Lee DR, Lee JU (2010) Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey. Metabolism 59(9):1300–1306CrossRefPubMedGoogle Scholar
  13. 13.
    Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6(10):2364–2373CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Korea Centers for Disease Control and Prevention. (2010) Guidelines for using the third year, fourth National Healthy and Nutition Examination Survey (KNHANES IV), 2009. In, Osong, Chungcheong Buk-Do, Republic of Korea, Korea Centers for Disease Control and PreventionGoogle Scholar
  15. 15.
    Korea Centers for Disease Control and Prevention (2011) Guidelines for using the Fifth National Healthy and Nutition Examination Survey (KNHANES V-1), 2010Google Scholar
  16. 16.
    Yoo K (2012) Education and quality control of pulmonary function test and chest X-ray in the National Health and Nutrition Examination Survey 2012. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases 2012 Dec. 10th Contract No.: 2012E3501200Google Scholar
  17. 17.
    Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365CrossRefPubMedGoogle Scholar
  18. 18.
    Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645CrossRefPubMedGoogle Scholar
  19. 19.
    Lee SY, Park HS, Kim DJ et al (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75(1):72–80CrossRefPubMedGoogle Scholar
  20. 20.
    Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825–830CrossRefPubMedGoogle Scholar
  22. 22.
    Yoon JH, Won JU, Ahn YS, Roh J (2014) Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and Nutrition Examination Survey. PLoS ONE 9(4):e94125CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Casanova C, de Torres JP, Navarro J et al (2010) Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182(8):1004–1010CrossRefPubMedGoogle Scholar
  24. 24.
    Mannino DM, Ford ES, Redd SC (2003) Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114(9):758–762CrossRefPubMedGoogle Scholar
  25. 25.
    Mapel D (2014) Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease. Curr Opin Pulm Med 20(2):186–193CrossRefPubMedGoogle Scholar
  26. 26.
    Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26(3):232–244CrossRefPubMedGoogle Scholar
  27. 27.
    Amann K, Benz K (2013) Structural renal changes in obesity and diabetes. Semin Nephrol 33(1):23–33CrossRefPubMedGoogle Scholar
  28. 28.
    Tanner RM, Brown TM, Muntner P (2012) Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep 14(2):152–159CrossRefPubMedGoogle Scholar
  29. 29.
    Baffi CW, Wood L, Winnica D et al (2016) Metabolic syndrome and the lung. Chest 149(6):1525–1534CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    MacIntyre NR, Selecky PA (2010) Is there a role for screening spirometry? Respir Care 55(1):35–42PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2017

Authors and Affiliations

  1. 1.Department of Family Medicine, Busan Paik HospitalInje University College of MedicineBusanRepublic of Korea

Personalised recommendations